- Home
- RNA vs CNO Comparison
RNA vs CNO Comparison
Compare RNA & CNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- CNO
- Stock Information
- Founded
- RNA 2012
- CNO 1979
- Country
- RNA United States
- CNO United States
- Employees
- RNA N/A
- CNO N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- CNO Accident &Health Insurance
- Sector
- RNA Health Care
- CNO Finance
- Exchange
- RNA Nasdaq
- CNO Nasdaq
- Market Cap
- RNA 4.0B
- CNO 3.8B
- IPO Year
- RNA 2020
- CNO 1987
- Fundamental
- Price
- RNA $69.83
- CNO $41.00
- Analyst Decision
- RNA Buy
- CNO Hold
- Analyst Count
- RNA 20
- CNO 5
- Target Price
- RNA $69.26
- CNO $43.60
- AVG Volume (30 Days)
- RNA 9.8M
- CNO 554.9K
- Earning Date
- RNA 11-07-2025
- CNO 11-03-2025
- Dividend Yield
- RNA N/A
- CNO 1.65%
- EPS Growth
- RNA N/A
- CNO 20.08
- EPS
- RNA N/A
- CNO 2.98
- Revenue
- RNA $10,729,000.00
- CNO $4,441,500,000.00
- Revenue This Year
- RNA N/A
- CNO N/A
- Revenue Next Year
- RNA $108.97
- CNO $3.27
- P/E Ratio
- RNA N/A
- CNO $13.84
- Revenue Growth
- RNA 1.23
- CNO N/A
- 52 Week Low
- RNA $21.51
- CNO $34.63
- 52 Week High
- RNA $70.51
- CNO $43.20
- Technical
- Relative Strength Index (RSI)
- RNA 79.30
- CNO 59.35
- Support Level
- RNA $69.50
- CNO $39.19
- Resistance Level
- RNA $69.86
- CNO $42.00
- Average True Range (ATR)
- RNA 0.88
- CNO 0.87
- MACD
- RNA 0.81
- CNO 0.08
- Stochastic Oscillator
- RNA 91.19
- CNO 66.61
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About CNO CNO Financial Group Inc.
CNO Financial Group Inc is a holding company for a group of insurance companies that offers middle-income American consumers insurance and securities products through exclusive agents, independent producers, and direct marketing. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.